| Literature DB >> 34064453 |
Rui Vilarinho1,2, Lúcia Serra1, Ricardo Coxo1, João Carvalho1,3, Cátia Esteves1, António Mesquita Montes2,4, Cátia Caneiras1,5,6.
Abstract
Patients with chronic obstructive pulmonary disease (COPD) in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) B group can be included in pulmonary rehabilitation (PR) settings outside the hospitals. This study aimed to explore the feasibility of a home-based pulmonary rehabilitation (HBPR) program and assess its impact on patients with COPD in the GOLD B group. A real-world, pre-post intervention study was conducted with 12 weeks of HBPR (presential home visits and phone calls) using the self-management program Living Well with COPD. The 1-min sit-to-stand test (1MSTS), modified Medical Research Council Questionnaire (mMRC), COPD Assessment Test (CAT), Hospital Anxiety and Depression Scale (HADS), and London Chest Activity of Daily Living (LCADL) were used to assess the impact. Pre-post differences and correlations between changes in outcomes were calculated. In 30 patients (71.6 years, FEV1 (%) 52.8), significant improvements (p < 0.05) were observed on 1MSTS (Pre 17.2, Post 21.2), mMRC (Pre 2.0, Post 1.0), CAT (Pre 16.3, Post 9.9), HADS (Pre 14.4, Post 9.6), and LCADL (Pre 21.0, Post 15.8), with no adverse events reported. When significant, correlations between changes in outcomes were moderate or strong (0.48 ≤ ρ ≤ 0.66). HBPR can be feasible and safe, and it shows the potential to significantly improve outcomes of patients with COPD in the GOLD B group.Entities:
Keywords: chronic respiratory disease; exercise training; functional outcomes; patient-reported outcomes; self-management
Year: 2021 PMID: 34064453 PMCID: PMC8148006 DOI: 10.3390/healthcare9050538
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1Flow diagram of patients through the study.
Participant characteristics.
| Characteristics | |
|---|---|
| Age, years | 71.6 ± 9.4 |
| Sex, male/female (%) | 12/18 (40.0/60.0) |
| BMI, kg/m2 | 26.4 ± 5.3 |
| GOLD stages, | |
| I | 2 (6.6) |
| II | 11 (36.7) |
| III | 16 (53.4) |
| IV | 1 (3.3) |
| FEV1, %predicted | 52.8 ± 18.3 |
| FEV1/FVC (%) | 50.6 ± 11.9 |
| Noninvasive ventilation, | 9 (30.0) |
| Long-term oxygen therapy, | 9 (30.0) |
| Comorbid illness, | |
| Coronary artery disease | 5 (17) |
| Arrhythmia | 6 (20) |
| Hypertension | 11 (37) |
| Diabetes | 6 (20) |
| Musculoskeletal | 11 (37) |
| Medication, | |
| SABA | 5 (17) |
| LABA | 4 (13) |
| SAMA | 4 (13) |
| LAMA | 9 (30) |
| LABA + LAMA | 11 (37) |
| LABA + ICS | 11 (37) |
| LABA + LAMA + ICS | 2 (7) |
| ICS | 11 (37) |
| Xanthines | 11 (37) |
| Heart rate at rest (bpm) | 76.7 ± 12.1 |
| Systolic BP at rest (mmHg) | 133.6 ± 15.7 |
| Diastolic BP at rest (mmHg) | 73.3 ± 11.3 |
| SpO2 at rest (%) | 94.1 ± 2.8 |
Data are expressed as mean ± standard deviation, unless otherwise stated. BMI, body mass index; GOLD, Global Initiative for Chronic Obstructive Lung Disease; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; SABA, short-acting β2-agonists; LABA, long-acting β2-agonists; SAMA, short-acting muscarinic antagonists; LAMA, long-acting muscarinic antagonists; ICS, inhaled corticosteroids; BP, blood pressure; SpO2, peripheral oxygen saturation.
Outcome values before and after home-based pulmonary rehabilitation.
| Variables ( | Pre-HBPR | Post-HBPR | ES | |
|---|---|---|---|---|
| 1MSTS (repetitions) | 17.2 ± 4.4 | 21.2 ± 5.3 | <0.001 | 1.137 |
| Dyspnea (mBorg) | 1.0 [0.0; 3.0] | 0.0 [0.0; 0.3] | 0.002 | −0.569 |
| Fatigue (mBorg) | 0.0 [0.0; 1.3] | 0.0 [0.0; 0.0] | 0.048 | −0.361 |
| mMRC (score) | 2.0 [1.0; 2.5] | 1.0 [1.0; 2.0] | 0.010 | −0.468 |
| CAT (score) | 16.3 ± 4.9 | 9.9 ± 5.2 | <0.001 | −1.020 |
| HADS (score) | 14.4 ± 5.8 | 9.6 ± 5.8 | 0.001 | −0.734 |
| HADS A (score) | 7.8 ± 4.2 | 5.1 ± 3.4 | <0.001 | −0.766 |
| HADS D (score) | 6.6 ± 2.8 | 4.6 ± 3.1 | 0.009 | −0.531 |
| LCADL (score) | 21.0 ± 7.4 | 15.8± 3.3 | <0.001 | −0.743 |
Data are expressed as mean ± standard deviation or median [percentile 25–75]. HBPR, home-based pulmonary rehabilitation; ES, effect size; mBorg, modified Borg scale; mMRC, modified Medical Research Council; CAT, COPD Assessment Test; HADS, The Hospital Anxiety and Depression scale; A, anxiety; D, depression; LCADL, London Chest Activity of Daily Living; 1MSTS, 1-min sit-to-stand.
Correlations between changes in outcomes after home-based pulmonary rehabilitation.
| Outcomes | ∆1MSTS | ∆mMRC | ∆CAT | ∆HADS | ∆LCADL |
|---|---|---|---|---|---|
| ∆1MSTS | --- | NS | −0.48 * | NS | NS |
| ∆mMRC | --- | --- | 0.51 ** | 0.62 ** | 0.55 ** |
| ∆CAT | --- | --- | --- | 0.66 *** | NS |
| ∆HADS | --- | --- | --- | --- | NS |
| ∆LCADL | --- | --- | --- | --- | --- |
Correlations are reported as Spearman’s ρ; * p < 0.05, ** p < 0.01, *** p < 0.001; mMRC, modified Medical Research Council; CAT, COPD Assessment Test; HADS, Hospital Anxiety and Depression Scale; LCADL, London Chest Activity of Daily Living; 1MSTS, 1-min sit-to-stand; NS, nonsignificant.